Disease-modifying capability of murine Flt3-ligand DCs in experimental autoimmune encephalomyelitis

Journal of Leukocyte Biology

Volumn 82, Issue 6, 2007, Pages 1510-1518

  Papenfuss, Tracey L ^a   Kithcart, Aaron P ^a   Powell, Nicole D ^a   McClain, Melanie A ^a   Gienapp, Ingrid E ^a   Shawler, Todd M ^a   Whitacre, Caroline C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Dendritic cells; MS EAE

Indexed keywords

B7 ANTIGEN; CD135 ANTIGEN; CD86 ANTIGEN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 4;

ALLERGIC ENCEPHALOMYELITIS; AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BONE MARROW CELL; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; DISEASE EXACERBATION; FEMALE; IMMUNOGENICITY; IMMUNOPHENOTYPING; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD11C; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; DISEASE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; KINETICS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PHENOTYPE; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

MURINAE; MUS;

EID: 37249081101     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0406257     Document Type: Article

References (54)

1. Raimondi, G., Thomson, A. W. (2005) Dendritic cells, tolerance and therapy of organ allograft rejection. Contrib. Nephrol. 146, 105-120.
2. O'Neill, D. W., Adams, S., Bhardwaj, N. (2004) Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 104, 2235-2246.
3. Adorini, L. (2003) Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann. N. Y. Acad. Sci. 987, 258-261.
4. Figdor, C. G., de Vries, I. J., Lesterhuis, W. J., Melief, C. J. (2004) Dendritic cell immunotherapy: mapping the way. Nat. Med. 10, 475-480.
5. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B., Palucka, K. (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18, 767-811.
6. Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., McKenna, H. J. (1996) Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953-1962.
7. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., Steinman, R. M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702.
8. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., Rossner, S., Koch, F., Romani, N., Schuler, G. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223, 77-92.
9. Huang, Y. M., Hussien, Y., Yarilin, D., Xiao, B. G., Liu, Y. J., Link, H. (2001) Interferon-β induces the development of type 2 dendritic cells. Cytokine 13, 264-271.
10. Gilliet, M., Boonstra, A., Paturel, C., Antonenko, S., Xu, X. L., Trinchieri, G., O'Garra, A., Liu, Y. J. (2002) The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 195, 953-958.
11. Brasel, K., McKenna, H. J., Charrier, K., Morrissey, P. J., Williams, D. E., Lyman, S. D. (1997) Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Blood 90, 3781-3788.
12. Brasel, K., McKenna, H. J., Morrissey, P. J., Charrier, K., Morris, A. E., Lee, C. C., Williams, D. E., Lyman, S. D. (1996) Hematologic effects of flt3 ligand in vivo in mice. Blood 88, 2004-2012.
13. Maraskovsky, E., Pulendran, B., Brasel, K., Teepe, M., Roux, E. R., Shortman, K., Lyman, S. D., McKenna, H. J. (1997) Dramatic numerical increase of functionally mature dendritic cells in FLT3 ligand-treated mice. Adv. Exp. Med. Biol. 417, 33-40.
14. Mach, N., Gillessen, S., Wilson, S. B., Sheehan, C., Mihm, M., Dranoff, G. (2000) Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60, 3239-3246.
15. Miller, G., Pillarisetty, V. G., Shah, A. B., Lahrs, S., DeMatteo, R. P. (2003) Murine Flt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties. J. Immunol. 170, 3554-3564.
16. Shaw, S. G., Maung, A. A., Steptoe, R. J., Thomson, A. W., Vujanovic, N. L. (1998) Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161, 2817-2824.
17. He, Y., Pimenov, A. A., Nayak, J. V., Plowey, J., Falo Jr., L. D., Huang, L. (2000) Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vivo. Hum. Gene Ther. 11, 547-554.
18. Shurin, M. R., Esche, C., Lotze, M. T. (1998) FLT3: receptor and ligand. Biology and potential clinical application. Cytokine Growth Factor Rev. 9, 37-48.
19. Karsunky, H., Merad, M., Cozzio, A., Weissman, I. L., Manz, M. G. (2003) Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J. Exp. Med. 198, 305-313.
20. Maraskovsky, E., Daro, E., Roux, E., Teepe, M., Maliszewski, C. R., Hoek, J., Caron, D., Lebsack, M. E., McKenna, H. J. (2000) In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96, 878-884.
21. Pulendran, B., Lingappa, J., Kennedy, M. K., Smith, J., Teepe, M., Rudensky, A., Maliszewski, C. R., Maraskovsky, E. (1997) Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J. Immunol. 159, 2222-2231.
22. Shurin, M. R., Pandharipande, P. P., Zorina, T. D., Haluszczak, C., Subbotin, V. M., Hunter, O., Brumfield, A., Storkus, W. J., Maraskovsky, E., Lotze, M. T. (1997) FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell. Immunol. 179, 174-184.
23. Pulendran, B., Banchereau, J., Burkeholder, S., Kraus, E., Guinet, E., Chalouni, C., Caron, D., Maliszewski, C., Davoust, J., Fay, J., Palucka, K. (2000) Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J. Immunol. 165, 566-572.
24. Teleshova, N., Jones, J., Kenney, J., Purcell, J., Bohm, R., Gettie, A., Pope, M. (2004) Short-term Flt3L treatment effectively mobilizes functional macaque dendritic cells. J. Leukoc. Biol. 75, 1102-1110.
25. D'Amico, A., Wu, L. (2003) The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J. Exp. Med. 198, 293-303.
26. Morse, M. A., Nair, S., Fernandez-Casal, M., Deng, Y., St Peter, M., Williams, R., Hobeika, A., Mosca, P., Clay, T., Cumming, R. I., Fisher, E., Clavien, P., Proia, A. D., Niedzwiecki, D., Caron, D., Lyerly, H. K. (2000) Preoperative mobilization of circulating dendritic cells by Flt3 ligand administration to patients with metastatic colon cancer. J. Clin. Oncol. 18, 3883-3893.
27. McQualter, J. L., Darwiche, R., Ewing, C., Onuki, M., Kay, T. W., Hamilton, J. A., Reid, H. H., Bernard, C. C. (2001) Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J. Exp. Med. 194, 873-882.
28. Broxmeyer, H. E., Lu, L., Cooper, S., Ruggieri, L., Li, Z. H., Lyman, S. D. (1995) Flt3 ligand stimulates/costimulates the growth of myeloid stem/ progenitor cells. Exp. Hematol. 23, 1121-1129.
29. Lyman, S. D., James, L., Johnson, L., Brasel, K., de Vries, P., Escobar, S. S., Downey, H., Splett, R. R., Beckmann, M. P., McKenna, H. J. (1994) Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cells. Blood 83, 2795-2801.
30. O'Keeffe, M., Hochrein, H., Vremec, D., Pooley, J., Evans, R., Woulfe, S., Shortman, K. (2002) Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99, 2122-2130.
31. Peron, J. M., Esche, C., Subbotin, V. M., Maliszewski, C., Lotze, M. T., Shurin, M. R. (1998) FLT3-ligand administration inhibits liver metastases: role of NK cells. J. Immunol. 161, 6164-6170.
32. Liu, Y. J. (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106, 259-262.
33. Naik, S. H., Proietto, A. I., Wilson, N. S., Dakic, A., Schnorrer, P., Fuchsberger, M., Lahoud, M. H., O'Keeffe, M., Shao, Q. X., Chen, W. F., Villadangos, J. A., Shortman, K., Wui, L. (2005) Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174, 6592-6597.
34. Tan, J. K., O'Neill, H. C. (2005) Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukoc. Biol. 78, 319-324.
35. Woltman, A. M., van Kooten, C. (2003) Functional modulation of dendritic cells to suppress adaptive immune responses. J. Leukoc. Biol. 73, 428-441.
36. Lutz, M. B., Kukutsch, N. A., Menges, M., Rossner, S., Schuler, G. (2000) Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur. J. Immunol. 30, 1048-1052.
37. Brasel, K., De Smedt, T., Smith, J. L., Maliszewski, C. R. (2000) Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96, 3029-3039.
38. Kohm, A.P., Carpentier, P.A., Miller, S.D. (2003) Regulation of experimental autoimmune encephalomyelitis (EAE) by CD4+CD25+ regulatory T cells. Novartis Found. Symp. 252, 45-52.
39. Baulieu, E., Schumacher, M. (2000) Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination. Steroids 65, 605-612.
40. O'Neill, H. C., Wilson, H. L., Quah, B., Abbey, J. L., Despars, G., Ni, K. (2004) Dendritic cell development in long-term spleen stromal cultures. Stem Cells 22, 475-486.
41. Mahnke, K., Schmitt, E., Bonifaz, L., Enk, A. H., Jonuleit, H. (2002) Immature, but not inactive: the tolerogenic function of immature dendritic cells. Immunol. Cell Biol. 80, 477-483.
42. Lugo-Villarino, G., Ito, S., Klinman, D. M., Glimcher, L. H. (2005) The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells. Proc. Natl. Acad. Sci. USA 102, 13248-13253.
43. Shinohara, M. L., Lu, L., Bu, J., Werneck, M. B., Kobayashi, K. S., Glimcher, L. H., Cantor, H. (2006) Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells. Nat. Immunol. 7, 498-506.
44. Towne, C. F., York, I. A., Watkin, L. B., Lazo, J. S., Rock, K. L. (2007) Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses. J. Immunol. 178, 6923-6930.
45. Song, Y. K., Liu, F., Zhang, G., Liu, D. (2002) Hydrodynamics-based transfection: simple and efficient method for introducing and expressing transgenes in animals by intravenous injection of DNA. Methods Enzymol. 346, 92-105.
46. Liu, F., Song, Y., Liu, D. (1999) Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258-1266.
47. Mempel, T. R., Henrickson, S. E., Von Andrian, U. H. (2004) T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154-159.
48. Morelli, A. E., Thomson, A. W. (2003) Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol. Rev. 196, 125-146.
49. Kollias, G., Kontoyiannis, D. (2002) Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev. 13, 315-321.
50. Xiao, B. G., Link, H. (1999) Antigen-specific T cells in autoimmune diseases with a focus on multiple sclerosis and experimental allergic encephalomyelitis. Cell. Mol. Life Sci. 56, 5-21.
51. Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N. A., Bogdan, C., Erb, K., Schuler, G., Lutz, M. B. (2002) Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15-21.
52. Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J., Akiba, H., Tushima, F., Azuma, M., Yagita, H., Sayegh, M. H., Khoury, S. J. (2003) Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J. Exp. Med. 198, 71-78.
53. Ito, T., Yang, M., Wang, Y. H., Lande, R., Gregorio, J., Perng, O. A., Qin, X. F., Liu, Y. J., Gilliet, M. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204, 105-115.
54. McAdam, A. J., Chang, T. T., Lumelsky, A. E., Greenfield, E. A., Boussiotis, V. A., Duke-Cohan, J. S., Chernova, T., Malenkovich, N., Jabs, C., Kuchroo, V. K., Ling, V., Collins, M., Sharpe, A. H., Freeman, G. J. (2000) Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J. Immunol. 165, 5035-5040.